1st Quarter - Report

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$110,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 17, 2008 $110,000 Replaced
1st Quarter - Amendment Jul 21, 2008 $110,000 Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Concerning Pediatric Cough and Cold Medicines; Regulation of over-the-couner medicines. S. 2311 and H.R. 4083.

LobbyistCovered position, as disclosed
ANDREW FISH —
ALLEN SEGAL New —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 2311 (110th), H.R. 4083 (110th)

Consumer Issues/Safety/Products CSP

Import Safety; H.R. 3610

LobbyistCovered position, as disclosed
ANDREW FISH —
ALLEN SEGAL New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 3610 (110th)

Alcohol and Drug Abuse ALC

Dextromethorphan Abuse S. 2237, S. 2274, S. 1378, H.R. 970

LobbyistCovered position, as disclosed
ANDREW FISH —
ALLEN SEGAL New —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 2274 (110th), S. 1378 (110th), H.R. 970 (110th), S. 2237 (110th)

Taxation/Internal Revenue Code TAX

Over-the-counter Drug Tax Deductibility

LobbyistCovered position, as disclosed
ANDREW FISH —
JUSTIN EDWARD NEUMANN —
ALLEN SEGAL New —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Budget/Appropriations BUD

Additional Funding for the Food and Drug Administration.

LobbyistCovered position, as disclosed
ANDREW FISH —
JUSTIN EDWARD NEUMANN —
ALLEN SEGAL New —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Communications/Broadcasting/Radio/TV COM

S. 2311, H.R. 4083. Issues concerning advertising of over-the-counter medicines.

LobbyistCovered position, as disclosed
ANDREW FISH —
ALLEN SEGAL New —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4083 (110th), S. 2311 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.